VA Hypothyroidism Ratings in 2026: Lab Evidence Guide

If you are researching VA hypothyroidism ratings, you may expect a TSH result to determine your percentage. The current rules don’t work that way. In 2026, VA rates hypothyroidism under Diagnostic Code 7903 based on myxedema, the timing of diagnosis or crisis stabilization, and lasting residuals.

Lab results still matter. They can confirm a thyroid disorder, show how it has progressed, and support a medical opinion about service connection. However, laboratory values alone don’t prove myxedema or guarantee a 30% or 100% evaluation.

VA hypothyroidism ratings in 2026 under DC 7903

As of August 2026, 38 CFR 4.119 provides two direct evaluations for hypothyroidism under Diagnostic Code 7903:

• 30% for hypothyroidism without myxedema.
• 100% for hypothyroidism manifesting as myxedema.

The current endocrine rating schedule is the controlling regulation. It also contains timing rules that can affect the assigned evaluation.

The 30% evaluation continues for six months after the initial diagnosis. The 100% evaluation continues for six months after a crisis has stabilized. After those periods, VA evaluates lasting residual effects under the body system they affect.

That means the final rating may depend on what remains after treatment. Eye problems, cardiovascular effects, mental impairment, digestive problems, or other residuals may require separate diagnostic codes. A VA Board decision applying DC 7903 discusses the requirement to rate residuals under the appropriate body-system criteria.

The present framework differs from the older hypothyroidism criteria used before the December 2017 schedule revision. If a claim involves an earlier period, the correct version of the regulation may affect the result. A general explanation of how VA disability ratings and compensation work can’t replace a review of the claim’s dates and medical evidence.

Why myxedema matters under the current schedule

The 100% standard is not triggered by an abnormal TSH, the need for levothyroxine, or ordinary hypothyroid symptoms alone. The regulation describes myxedema through signs of serious, broad impairment.

The listed manifestations include:

• Cold intolerance and muscular weakness.
• Cardiovascular involvement, such as hypotension, bradycardia, or pericardial effusion.
• Mental disturbance, including dementia, slowed thought, or depression.

A claimant should not assume that one symptom or one abnormal lab result meets the 100% standard. The record should contain a medical diagnosis and findings that connect the manifestations to hypothyroidism.

Severe fatigue, weight changes, constipation, or difficulty concentrating may support the existence of thyroid disease. Those symptoms don’t automatically establish myxedema under the current code. The medical evidence must show how the condition affects the veteran during the relevant rating period.

An abnormal thyroid panel can support a diagnosis, but a 100% DC 7903 claim requires evidence of myxedema and its clinical manifestations.

Useful records may include hospital reports, vital signs, electrocardiograms, echocardiograms, mental health evaluations, neurological findings, and physician notes. If emergency treatment stabilized the condition, records from before and after that treatment can help establish the proper temporary period.

Which lab evidence supports a hypothyroidism claim?

TSH and free T4 are usually the most important laboratory results for documenting primary hypothyroidism. An elevated TSH with a low free T4 commonly supports overt primary hypothyroidism. An elevated TSH with a normal free T4 may indicate a subclinical pattern, depending on the clinical record.

TSH isn’t the only pattern that matters. Central hypothyroidism can involve a low free T4 with a low or normal TSH. For that reason, VA should consider the full thyroid panel and the doctor’s interpretation instead of treating one number as conclusive.

T3 results may remain normal in some people with hypothyroidism. A normal T3 therefore doesn’t necessarily disprove the diagnosis. Thyroid peroxidase antibodies can support an autoimmune cause, such as Hashimoto’s thyroiditis, but antibody levels don’t determine whether VA should assign 30% or 100%.

A strong medical file usually includes:

• Dated TSH and free T4 results, with the laboratory’s reference ranges.
• Earlier service treatment records and post-service testing that show when the abnormal pattern appeared.
• Endocrinology notes explaining the diagnosis, cause, severity, and treatment response.
• Medication records showing levothyroxine prescriptions, dose changes, and continuing treatment.
• Testing and clinical notes from periods of worsening, hospitalization, or suspected myxedema.

Serial results are often more useful than one isolated test. A timeline can show whether the condition began during service, became chronic after discharge, or worsened during a defined period.

Treatment also affects the laboratory record. A normal TSH while taking levothyroxine may show that treatment is working. It doesn’t necessarily mean the underlying thyroid disorder disappeared. At the same time, medication use alone doesn’t establish a current 30% or 100% rating under DC 7903.

Never stop or change prescribed thyroid medication to produce an abnormal result. The relevant evidence is the veteran’s actual medical history, including the condition before treatment and the symptoms that remain despite treatment.

Lab results must connect the condition to military service

Diagnosis and disability evaluation are separate questions. A lab report may establish that a veteran has hypothyroidism, but it usually doesn’t prove that military service caused the condition.

A service-connection claim generally needs evidence of a current disability, an in-service disease, injury, event, or exposure, and a link between that event and the current condition. Service treatment records with abnormal thyroid results can be valuable, especially when they are close to the onset of symptoms or diagnosis.

When the first abnormal testing appears after service, a medical nexus opinion may become more important. The opinion should explain why the condition is related to service, rather than simply stating that the veteran served and later developed hypothyroidism.

The doctor should review relevant records and address the timeline. A useful opinion may discuss earlier symptoms, service laboratory findings, documented exposures, treatment history, and the medical reasons supporting a connection.

Secondary service connection requires the same care. If a veteran believes hypothyroidism resulted from another service-connected condition or its treatment, the medical opinion should explain causation or aggravation. For aggravation, the record should address the baseline severity and the degree of worsening.

A compensation and pension examination may review the diagnosis, symptoms, laboratory results, and functional effects. Veterans should describe when symptoms began, how often they occur, and what daily activities or work tasks they affect. They should also report cardiovascular, mental, muscular, digestive, or eye symptoms accurately.

Don’t minimize symptoms because medication controls some of them. Don’t exaggerate them either. Consistent reports supported by dated medical records are easier to evaluate.

What to review when the assigned rating seems wrong

When reviewing VA hypothyroidism ratings, start with the decision’s diagnostic code, effective dates, and stated reasons. Check whether VA applied DC 7903 correctly and whether it recognized the six-month period after diagnosis or crisis stabilization.

Next, look for missing evidence. The decision may mention a TSH result but omit free T4 values, medication history, hospitalization records, or a doctor’s findings about myxedema. It may also accept the diagnosis while failing to evaluate residual effects under another body-system code.

The correct response depends on the error. A missing nexus usually calls for a well-supported medical opinion. An incorrect percentage may require evidence about symptoms, clinical findings, residuals, or the dates when those findings existed. An appeal should address the reason for denial instead of submitting unrelated laboratory reports.

Earlier claim periods deserve separate attention. VA may need to apply older criteria to an earlier period and current criteria to a later one. That can affect staged ratings, especially when the evidence shows a change in severity.

The percentage also affects monthly compensation under broader VA rules. Combined ratings aren’t calculated by ordinary addition, and dependents can change payment amounts. Florida veterans can review the 2026 VA disability compensation rates while examining the financial effect of a decision.

A VA-accredited attorney or representative can compare the medical timeline with the applicable rating criteria. That review is especially useful when the decision overlooks residuals, misreads the evidence, or uses the wrong rating period.

Conclusion

VA hypothyroidism ratings in 2026 don’t depend on a single TSH number. DC 7903 provides 30% for hypothyroidism without myxedema and 100% for hypothyroidism manifesting as myxedema, with temporary timing rules and separate evaluation of lasting residuals.

The strongest record combines serial thyroid labs, treatment history, service records, medical opinions, and documentation of symptoms. Lab evidence proves important facts, but the complete medical timeline determines how those facts support the claim.